This inventor holds 1 USPTO granted patent. Top assignee: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Qingfeng Xia: Innovator in Pharmaceutical Chemistry
Introduction
Qingfeng Xia is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of nitrogen-containing heterocyclic compounds. His work focuses on enhancing the solubility and stability of pharmaceutical compositions.
Latest Patents
Qingfeng Xia holds 1 patent for his invention titled "Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof." This patent provides salts of a compound with ATX inhibitory activity. The salts include inorganic and organic acid salts, along with solid forms such as crystal forms. The disclosed salts exhibit good solubility, stability, and hygroscopicity, making them suitable for medicinal use. Additionally, the preparation methods are simple and convenient, allowing for large-scale production.
Career Highlights
Qingfeng Xia is associated with the Wuhan Humanwell Innovative Drug Research and Development Center Limited Company. His role at this institution has allowed him to focus on innovative drug research and development, contributing to advancements in pharmaceutical sciences.
Collaborations
Qingfeng Xia has worked alongside his coworker, Yang Yue, in various research initiatives. Their collaboration has fostered a productive environment for innovation in drug development.
Conclusion
Qingfeng Xia's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His patented work on nitrogen-containing heterocyclic compounds demonstrates the potential for improved medicinal applications.